SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases
Rheumatology (Oxford)
.
2022 Nov 2;61(11):4229-4231.
doi: 10.1093/rheumatology/keac431.
Authors
Ethan S Sen
1
2
,
Dalila Julandani
3
,
Athimalaipet V Ramanan
3
4
Affiliations
1
Department of Paediatric Rheumatology, Great North Children's Hospital.
2
Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne.
3
Department of Paediatric Rheumatology, Bristol Royal Hospital for Children.
4
Translational Health Sciences, University of Bristol, Bristol, UK.
PMID:
35916712
PMCID:
PMC9384573
DOI:
10.1093/rheumatology/keac431
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adolescent
COVID-19 Vaccines
COVID-19*
Child
Humans
Rheumatic Diseases*
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines